藥明生物漲近 5% 旗下無錫子公司已從美國未經核實名單中移除

智通財經
2022.10.10 01:36
截至發稿，藥明生物漲 4.88%。根據公司週一公告，10 月 7 日，藥明生物旗下的子公司之一無錫藥明生物技術股份有限公司在中國商務部協調下成功完成美國商務部現場最終用户訪問後， 已被美國商務部從未經核實名單中移除。目前該公司仍積極與相關政府機構合作， 推動另一子公司上海藥明生物技術有限公司從未經核實名單移除。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.